Ryan Bliss has been serving clients in the biopharmaceutical industry since 2016.  He has extensive experience in market access, brand / launch strategy development, and pipeline asset opportunity assessment. His work spans a range of therapeutic areas, with specific expertise in oncology across solid & hematological malignancies, and experience in ophthalmology & immunology.  Prior to joining the Blue Matter team, Ryan served in consulting roles at Navigant / Guidehouse.  He earned a BSE in Chemical and Biomolecular Engineering at the University of Pennsylvania.